Diagnosis and management of spermatic cord tumors

Marco Moschini, Agostino Mattei

Research output: Contribution to journalArticle

Abstract

PURPOSE OF REVIEW: Spermatic cord tumors (SCT) are very rare. The present review discusses the most recent literature regarding clinical presentation, pathological characteristics, diagnosis, and management of SCT. RECENT FINDINGS: Although the majority of SCT are benign, when malignant almost all SCT are sarcomas. Liposarcomas are the most common; whereas rhabdomyosarcomas recorded the highest tendency of develop distant metastases. The clinical presentation is usually a unilateral solid slow-growing mass at the level of the inguinal canal and of the scrotum. Surgical excision represents the most common used treatment, and considering the risk in developing local recurrence, radical inguinal orchiectomy and resection of the tumor with negative microscopic surgical margins is mandatory. Adjuvant therapies such as radiotherapy and chemotherapy have been suggested in selected patients, but clear data to demonstrate any improvement in survival are not available. SUMMARY: SCT are rare tumors with high risk of misdiagnosis or mistreatment. The majority are benign, but when malignant almost all are sarcomas. A surgical excision is the treatment of choice; however, no clear data exists documenting the efficacy of a multimodal treatment in reducing high local recurrence rates after surgery.

Original languageEnglish
JournalCurrent Opinion in Urology
DOIs
Publication statusAccepted/In press - Jun 3 2016

Fingerprint

Spermatic Cord
Neoplasms
Sarcoma
Inguinal Canal
Recurrence
Liposarcoma
Combined Modality Therapy
Scrotum
Orchiectomy
Rhabdomyosarcoma
Groin
Diagnostic Errors
Radiotherapy
Therapeutics
Neoplasm Metastasis
Drug Therapy
Survival

ASJC Scopus subject areas

  • Urology

Cite this

Diagnosis and management of spermatic cord tumors. / Moschini, Marco; Mattei, Agostino.

In: Current Opinion in Urology, 03.06.2016.

Research output: Contribution to journalArticle

Moschini, Marco ; Mattei, Agostino. / Diagnosis and management of spermatic cord tumors. In: Current Opinion in Urology. 2016.
@article{85604fe7259e47ce9af46160a3cd765a,
title = "Diagnosis and management of spermatic cord tumors",
abstract = "PURPOSE OF REVIEW: Spermatic cord tumors (SCT) are very rare. The present review discusses the most recent literature regarding clinical presentation, pathological characteristics, diagnosis, and management of SCT. RECENT FINDINGS: Although the majority of SCT are benign, when malignant almost all SCT are sarcomas. Liposarcomas are the most common; whereas rhabdomyosarcomas recorded the highest tendency of develop distant metastases. The clinical presentation is usually a unilateral solid slow-growing mass at the level of the inguinal canal and of the scrotum. Surgical excision represents the most common used treatment, and considering the risk in developing local recurrence, radical inguinal orchiectomy and resection of the tumor with negative microscopic surgical margins is mandatory. Adjuvant therapies such as radiotherapy and chemotherapy have been suggested in selected patients, but clear data to demonstrate any improvement in survival are not available. SUMMARY: SCT are rare tumors with high risk of misdiagnosis or mistreatment. The majority are benign, but when malignant almost all are sarcomas. A surgical excision is the treatment of choice; however, no clear data exists documenting the efficacy of a multimodal treatment in reducing high local recurrence rates after surgery.",
author = "Marco Moschini and Agostino Mattei",
year = "2016",
month = "6",
day = "3",
doi = "10.1097/MOU.0000000000000318",
language = "English",
journal = "Current Opinion in Urology",
issn = "0963-0643",
publisher = "Lippincott Williams and Wilkins",

}

TY - JOUR

T1 - Diagnosis and management of spermatic cord tumors

AU - Moschini, Marco

AU - Mattei, Agostino

PY - 2016/6/3

Y1 - 2016/6/3

N2 - PURPOSE OF REVIEW: Spermatic cord tumors (SCT) are very rare. The present review discusses the most recent literature regarding clinical presentation, pathological characteristics, diagnosis, and management of SCT. RECENT FINDINGS: Although the majority of SCT are benign, when malignant almost all SCT are sarcomas. Liposarcomas are the most common; whereas rhabdomyosarcomas recorded the highest tendency of develop distant metastases. The clinical presentation is usually a unilateral solid slow-growing mass at the level of the inguinal canal and of the scrotum. Surgical excision represents the most common used treatment, and considering the risk in developing local recurrence, radical inguinal orchiectomy and resection of the tumor with negative microscopic surgical margins is mandatory. Adjuvant therapies such as radiotherapy and chemotherapy have been suggested in selected patients, but clear data to demonstrate any improvement in survival are not available. SUMMARY: SCT are rare tumors with high risk of misdiagnosis or mistreatment. The majority are benign, but when malignant almost all are sarcomas. A surgical excision is the treatment of choice; however, no clear data exists documenting the efficacy of a multimodal treatment in reducing high local recurrence rates after surgery.

AB - PURPOSE OF REVIEW: Spermatic cord tumors (SCT) are very rare. The present review discusses the most recent literature regarding clinical presentation, pathological characteristics, diagnosis, and management of SCT. RECENT FINDINGS: Although the majority of SCT are benign, when malignant almost all SCT are sarcomas. Liposarcomas are the most common; whereas rhabdomyosarcomas recorded the highest tendency of develop distant metastases. The clinical presentation is usually a unilateral solid slow-growing mass at the level of the inguinal canal and of the scrotum. Surgical excision represents the most common used treatment, and considering the risk in developing local recurrence, radical inguinal orchiectomy and resection of the tumor with negative microscopic surgical margins is mandatory. Adjuvant therapies such as radiotherapy and chemotherapy have been suggested in selected patients, but clear data to demonstrate any improvement in survival are not available. SUMMARY: SCT are rare tumors with high risk of misdiagnosis or mistreatment. The majority are benign, but when malignant almost all are sarcomas. A surgical excision is the treatment of choice; however, no clear data exists documenting the efficacy of a multimodal treatment in reducing high local recurrence rates after surgery.

UR - http://www.scopus.com/inward/record.url?scp=84973353631&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84973353631&partnerID=8YFLogxK

U2 - 10.1097/MOU.0000000000000318

DO - 10.1097/MOU.0000000000000318

M3 - Article

JO - Current Opinion in Urology

JF - Current Opinion in Urology

SN - 0963-0643

ER -